glp-1 shortage us FDA says that the is over GLP-1 Pipeline Update: August 2025

Dora Matis - April 13, 2026 GLP-1 receptor agonists such as semaglutide-based medications support blood sugar control, weight loss, and cardiovascular health through effects on insulin, appetite, and gastric emptying

This article will explore how digital solutions are revolutionising the management of obesity for patients and healthcare systems, and what this means for the pharmaceutical companies behind new transformative pharmacological anti-obesity agents

156 Besides, with the consumption of extracellular glutamine, GDH can also catalyze ammonia derived from glutaminolysis and -KG to support the synthesis of glutamate and downstream metabolites by reductive amination in a NADPH consumption manner to meet the cancer cells growth

Ask your doctor for medical advice about side effects before drinking alcohol

Risk of heart failure in patients with nonalcoholic fatty liver disease: JACC review topic of the week

Like the medications used by humans, the experimental pet treatments are designed to regulate appetite by mimicking natural hormones that slow digestion and signal fullness